What does APOTEEK JACOBS do?

APOTEEK JACOBS is a pharmacy in Ranst. Public Limited, started on 25 January 1995, 1 establishment.

What is the address of APOTEEK JACOBS?

The registered office of APOTEEK JACOBS is located at Lievevrouwestraat 36, 2520 Ranst.

Is APOTEEK JACOBS still active?

Yes. According to the CBE (29 October 2026) APOTEEK JACOBS is active, legal situation “Normale toestand”, started on 25 January 1995.

Is APOTEEK JACOBS registered on Peppol?

Yes, APOTEEK JACOBS is registered on the Peppol network with ID 0208:0454398775.

What is the enterprise number of APOTEEK JACOBS?

The enterprise number of APOTEEK JACOBS is BE0454398775.

When was APOTEEK JACOBS founded?

APOTEEK JACOBS was founded on 25 January 1995.

Who are the directors of APOTEEK JACOBS?

According to the 2025 annual accounts, the directors of APOTEEK JACOBS are: Katrien PIOT.

Is APOTEEK JACOBS a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 25 January 1995; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did APOTEEK JACOBS make in 2025?

APOTEEK JACOBS posted a profit after taxes of € 105,565 in financial year 2025.

What is the revenue of APOTEEK JACOBS?

As a small company, APOTEEK JACOBS is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 210,359.

How much does an employee at APOTEEK JACOBS earn?

The average wage cost per full-time employee at APOTEEK JACOBS was € 92,800 in 2023: staff costs of € 92,778 for 1 FTE, according to the annual account at the National Bank. That is the employer's cost, not net pay.

APOTEEK JACOBS (Public Limited) - Ranst - BE0454398775

Dossier APOTEEK JACOBS, printed on 29 October 2026 from databakkes.be/en/0454398775/apoteek-jacobs. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

APOTEEK JACOBS from Ranst, company number BE0454398775, closed financial year 2025 with a result of € 105,565 after tax. For that financial year APOTEEK JACOBS recorded a gross margin of € 210,359 and equity of € 200,991. Compared with financial year 2024, the result moved from € 86,664 to € 105,565. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on June 2, 2026.

What it is worth Growing

€ 200,991

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 105,565

▲ 22% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 80,969

▼ 27% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 105,000 paid out

99 % of the profit went to the shareholders, mostly to LUPIO (100 % of the shares). That is where the money ends up.

People and assets in 2025

Wage cost

€ 43,969

▼ 55% vs 2024

Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Vehicles and equipment

€ 10,796

▼ 22% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 89,365

▲ 66% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes and wages

€ 7,141

▼ 68% vs 2024

Taxes, VAT and social contributions still to pay.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 238,552 Gross margin 2022: € 238,552 First fiscal year in the series	€ 230,574 Gross margin 2023: € 230,574 ▼ 3% vs 2022 (€ 238,552) Unfavourable step	€ 241,497 Gross margin 2024: € 241,497 ▲ 5% vs 2023 (€ 230,574) Favourable step	€ 210,359 Gross margin 2025: € 210,359 ▼ 13% vs 2024 (€ 241,497) Unfavourable step	▼ 13%
Profit after taxes	€ 111,290 Profit after taxes 2022: € 111,290 First fiscal year in the series	€ 80,946 Profit after taxes 2023: € 80,946 ▼ 27% vs 2022 (€ 111,290) Unfavourable step	€ 86,664 Profit after taxes 2024: € 86,664 ▲ 7% vs 2023 (€ 80,946) Favourable step	€ 105,565 Profit after taxes 2025: € 105,565 ▲ 22% vs 2024 (€ 86,664) Favourable step	▲ 22%
Equity	€ 232,816 Equity 2022: € 232,816 First fiscal year in the series	€ 213,763 Equity 2023: € 213,763 ▼ 8% vs 2022 (€ 232,816) Unfavourable step	€ 200,426 Equity 2024: € 200,426 ▼ 6% vs 2023 (€ 213,763) Unfavourable step	€ 200,991 Equity 2025: € 200,991 Unchanged (€ 200,426) Favourable step
Total debts	€ 159,198 Total debts 2022: € 159,198 First fiscal year in the series	€ 194,025 Total debts 2023: € 194,025 ▲ 22% vs 2022 (€ 159,198) Unfavourable step	€ 176,156 Total debts 2024: € 176,156 ▼ 9% vs 2023 (€ 194,025) Favourable step	€ 201,660 Total debts 2025: € 201,660 ▲ 14% vs 2024 (€ 176,156) Unfavourable step	▲ 14%
Cash	€ 87,707 Cash 2022: € 87,707 First fiscal year in the series	€ 101,023 Cash 2023: € 101,023 ▲ 15% vs 2022 (€ 87,707) Favourable step	€ 110,238 Cash 2024: € 110,238 ▲ 9% vs 2023 (€ 101,023) Favourable step	€ 80,969 Cash 2025: € 80,969 ▼ 27% vs 2024 (€ 110,238) Unfavourable step	▼ 27%
Land & buildings	€ 89,438 Land & buildings 2022: € 89,438 First fiscal year in the series	€ 77,319 Land & buildings 2023: € 77,319 ▼ 14% vs 2022 (€ 89,438) Unchanged	€ 65,190 Land & buildings 2024: € 65,190 ▼ 16% vs 2023 (€ 77,319) Unchanged	€ 53,060 Land & buildings 2025: € 53,060 ▼ 19% vs 2024 (€ 65,190) Unchanged	▼ 19%
Retained profit	€ 170,654 Retained profit 2022: € 170,654 First fiscal year in the series	€ 151,600 Retained profit 2023: € 151,600 ▼ 11% vs 2022 (€ 170,654) Unfavourable step	€ 138,264 Retained profit 2024: € 138,264 ▼ 9% vs 2023 (€ 151,600) Unfavourable step	€ 138,829 Retained profit 2025: € 138,829 Unchanged (€ 138,264) Favourable step
Dividend	€ 102,500 Dividend 2022: € 102,500 First fiscal year in the series	€ 100,000 Dividend 2023: € 100,000 ▼ 2% vs 2022 (€ 102,500) Unchanged	€ 100,000 Dividend 2024: € 100,000 Unchanged (€ 100,000) Unchanged	€ 105,000 Dividend 2025: € 105,000 ▲ 5% vs 2024 (€ 100,000) Unchanged	▲ 5%
Balance sheet total	€ 392,014 Balance sheet total 2022: € 392,014 First fiscal year in the series	€ 407,787 Balance sheet total 2023: € 407,787 ▲ 4% vs 2022 (€ 392,014) Unchanged	€ 376,582 Balance sheet total 2024: € 376,582 ▼ 8% vs 2023 (€ 407,787) Unchanged	€ 402,651 Balance sheet total 2025: € 402,651 ▲ 7% vs 2024 (€ 376,582) Unchanged	▲ 7%
Employees (FTE)	0.9 Employees (FTE) 2022: 0.9 First fiscal year in the series	1 Employees (FTE) 2023: 1 ▲ 0.1 vs 2022 (0.9) Unchanged	-	-

Key figures of APOTEEK JACOBS, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to APOTEEK JACOBS?

What happened at APOTEEK JACOBS in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jun 2, 2026 New annual accounts for financial year 2025: profit of € 105,565 (▲ 22% vs 2024). Source: NBB ↗
2021 Katrien PIOT became a director. NBB
Apr 14, 1995 New establishment in Ranst. KBO
Jan 25, 1995 Start of the company according to the CBE. KBO

In short

From € 111,290 profit in 2022 to € 105,565 profit in 2025.

Paid € 151,502 in corporate taxes since 2022.

Best year ever: 2022, with € 111,290 profit.

On average € 230,600 of value added per employee in 2023.

Original PDFs at the National Bank ↗

Management

LUPIO 100%

The stake of LUPIO comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.

APOTEEK JACOBS

Behind APOTEEK JACOBS is Katrien PIOT. The shares are held by LUPIO (100%).

Directors

According to the 2025 annual accounts

Katrien PIOT

Director

since 2021

Shareholders

LUPIO

100%

Participations

No participations in other companies reported.

Establishments

Establishment units

Physical locations of this company

Registered office

Lievevrouwestraat 36

2520 Ranst

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0454.398.775

VAT number

BE 0454.398.775

Registered office

Lievevrouwestraat 36, 2520 Ranst

Names & denominations

APOTEEK JACOBS

Enterprise type

Rechtspersoon

Legal form

Public limited company

Legal situation

Normale toestand

Start date

25 January 1995

Peppol

Active · Active since 8 May 2025

Activities · NACE

Detailhandel in farmaceutische producten

Apothekers

View on CBE Public ↗ Annual accounts (NBB) ↗

APOTEEK JACOBS

Financials

What happened to APOTEEK JACOBS?

Management

Directors

Shareholders

Participations

Establishments

Establishment units

Details

Frequently asked questions